US Stock MarketDetailed Quotes
HBIO Harvard Bioscience
- 3.250
- +0.100+3.17%
Trading Jul 30 12:28 ET
141.15MMarket Cap-16250P/E (TTM)
3.265High3.130Low19.29KVolume3.130Open3.150Pre Close60.97KTurnover0.06%Turnover RatioLossP/E (Static)43.43MShares5.56052wk High2.05P/B114.00MFloat Cap2.70052wk Low--Dividend TTM35.08MShs Float43.944Historical High--Div YieldTTM4.29%Amplitude1.390Historical Low3.160Avg Price1Lot Size
Harvard Bioscience Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -18.23%24.51M | -0.96%112.25M | -0.96%28.15M | -5.79%25.36M | -1.54%28.76M | 4.16%29.98M | -4.68%113.34M | -14.00%28.43M | -9.24%26.92M | 0.04%29.21M |
| Operating revenue | -18.23%24.51M | -0.96%112.25M | -0.96%28.15M | -5.79%25.36M | -1.54%28.76M | 4.16%29.98M | -4.68%113.34M | -14.00%28.43M | -9.24%26.92M | 0.04%29.21M |
| Cost of revenue | -16.24%9.74M | -12.07%46.18M | -6.08%11.83M | -27.89%10.64M | -3.86%12.09M | -7.71%11.63M | 2.47%52.52M | -6.68%12.59M | 10.45%14.75M | -2.13%12.57M |
| Gross profit | -19.48%14.77M | 8.64%66.07M | 3.11%16.33M | 20.99%14.73M | 0.22%16.67M | 13.41%18.35M | -10.10%60.82M | -19.05%15.83M | -25.36%12.17M | 1.74%16.64M |
| Operating expense | 2.74%17.05M | -5.60%64.18M | -1.52%16.04M | -4.96%15.66M | -9.37%15.88M | -6.22%16.6M | 3.66%67.99M | -8.80%16.29M | 4.56%16.48M | 7.51%17.52M |
| Selling and administrative expenses | -3.61%11.87M | -5.34%46.89M | -2.58%11.51M | -4.97%11.54M | -8.25%11.53M | -5.38%12.31M | 1.20%49.53M | -12.24%11.81M | 4.31%12.14M | 3.62%12.57M |
| -Selling and marketing expense | -1.24%5.9M | -3.73%24.11M | 4.57%6.22M | -1.50%5.73M | -6.21%6.18M | -10.60%5.98M | 1.62%25.04M | -19.00%5.95M | -5.89%5.82M | 14.96%6.59M |
| -General and administrative expense | -5.86%5.96M | -6.99%22.78M | -9.84%5.29M | -8.18%5.81M | -10.50%5.35M | 0.14%6.33M | 0.77%24.49M | -4.12%5.86M | 15.87%6.32M | -6.53%5.98M |
| Research and development costs | -0.41%2.89M | -4.58%11.76M | 10.57%3.15M | -0.11%2.76M | -15.44%2.96M | -10.03%2.9M | 14.17%12.33M | -3.46%2.85M | 3.87%2.76M | 29.47%3.5M |
| Depreciation amortization depletion | -3.96%1.33M | -9.75%5.53M | -14.91%1.39M | -13.42%1.36M | -4.47%1.39M | -5.32%1.39M | 4.83%6.12M | 12.26%1.63M | 7.75%1.57M | -0.75%1.45M |
| -Depreciation and amortization | -3.96%1.33M | -9.75%5.53M | -14.91%1.39M | -13.42%1.36M | -4.47%1.39M | -5.32%1.39M | 4.83%6.12M | 12.26%1.63M | 7.75%1.57M | -0.75%1.45M |
| Other operating expenses | --966K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -230.30%-2.28M | 126.43%1.89M | 161.71%282K | 78.33%-933K | 190.25%796K | 214.99%1.75M | -446.85%-7.17M | -126.90%-457K | -885.77%-4.31M | -1,620.69%-882K |
| Net non-operating interest income expense | 22.90%-751K | -40.93%-3.59M | 11.78%-794K | -17.76%-882K | -82.72%-941K | -153.65%-974K | -65.45%-2.55M | -137.47%-900K | -100.80%-749K | -36.60%-515K |
| Non-operating interest expense | -22.90%751K | 40.93%3.59M | -11.78%794K | 17.76%882K | 82.72%941K | 153.65%974K | 65.45%2.55M | 137.47%900K | 100.80%749K | 36.60%515K |
| Other net income (expense) | -436.57%-1.45M | -260.56%-859K | -227.10%-591K | 243.29%1.25M | -140.54%-1.95M | 108.45%432K | 180.33%535K | 346.03%465K | 380.77%365K | 1,639.30%4.82M |
| Gain on sale of security | ---1.31M | ---632K | ---259K | --1.21M | ---1.58M | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | --0 | --0 | --0 | --0 | ---- | --233K | --0 | --544K | --4.88M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---233K | --0 | ---544K | ---4.88M |
| Other non- operating income (expenses) | -132.87%-142K | -175.17%-227K | -171.40%-332K | 125.14%45K | -500.00%-372K | 453.85%432K | 145.35%302K | 346.03%465K | -37.69%-179K | 80.19%-62K |
| Income before tax | -471.50%-4.48M | 72.15%-2.56M | -23.65%-1.1M | 88.02%-562K | -161.33%-2.1M | 117.20%1.21M | -6,456.43%-9.18M | -178.87%-892K | -10,522.22%-4.69M | 641.30%3.42M |
| Income tax | -64.10%210K | 154.90%859K | -7.62%715K | 152.68%677K | -213.39%-1.12M | 523.91%585K | 127.70%337K | 355.29%774K | -697.67%-1.29M | 544.14%986K |
| Net income | -854.66%-4.69M | 64.11%-3.42M | -9.12%-1.82M | 63.61%-1.24M | -140.25%-980K | 109.04%622K | -3,204.17%-9.52M | -273.36%-1.67M | -1,902.94%-3.41M | 693.90%2.44M |
| Net income continuous Operations | -854.66%-4.69M | 64.11%-3.42M | -9.12%-1.82M | 63.61%-1.24M | -140.25%-980K | 109.04%622K | -3,204.17%-9.52M | -273.36%-1.67M | -1,902.94%-3.41M | 693.90%2.44M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -854.66%-4.69M | 64.11%-3.42M | -9.12%-1.82M | 63.61%-1.24M | -140.25%-980K | 109.04%622K | -3,204.17%-9.52M | -273.36%-1.67M | -1,902.94%-3.41M | 693.90%2.44M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -854.66%-4.69M | 64.11%-3.42M | -9.12%-1.82M | 63.61%-1.24M | -140.25%-980K | 109.04%622K | -3,204.17%-9.52M | -273.36%-1.67M | -1,902.94%-3.41M | 693.90%2.44M |
| Basic earnings per share | -1,200.00%-0.11 | 65.22%-0.08 | 0.00%-0.04 | 62.50%-0.03 | -133.33%-0.02 | 105.88%0.01 | -2,200.00%-0.23 | -300.00%-0.04 | -1,818.01%-0.08 | 700.00%0.06 |
| Diluted earnings per share | -1,200.00%-0.11 | 65.22%-0.08 | 0.00%-0.04 | 62.50%-0.03 | -133.33%-0.02 | 105.88%0.01 | -2,200.00%-0.23 | -300.00%-0.04 | -1,818.01%-0.08 | 700.00%0.06 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg